Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decapeptyl vs Zoladex for prostate volume reduction before radiotherapy
2008-007028-25Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Jul 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of triptorelin in prostate cancer (PCa) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Reduction in prostate size. Started Jul 2010; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-007028-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007028-25.